feed,title,long_url,short_url
Benzinga,Sanofi Opts To Terminate Rare Disease Program With Regulus Therapeutics,https://benzinga.com/general/biotech/23/01/30328129/sanofi-opts-to-terminate-rare-disease-program-with-regulus-therapeutics,https://da.gd/Oh1faH
Benzinga,Is Tesla Elon Musk's 'Private Company Masquerading As A Public Company?' â€” Board Under Pressure As Dissenting Voices Call For Overhaul,https://benzinga.com/analyst-ratings/analyst-color/23/01/30325643/is-tesla-elon-musks-private-company-masquerading-as-a-public-company-board-under-pr,https://da.gd/NCQSWI
